These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Activation by insulin and amino acids of signaling components leading to translation initiation in skeletal muscle of neonatal pigs is developmentally regulated. Suryawan A; Orellana RA; Nguyen HV; Jeyapalan AS; Fleming JR; Davis TA Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1597-605. PubMed ID: 17878222 [TBL] [Abstract][Full Text] [Related]
43. p38 mitogen-activated protein kinase mediates lipopolysaccharide, not interferon-gamma, -induced inducible nitric oxide synthase expression in mouse BV2 microglial cells. Han IO; Kim KW; Ryu JH; Kim WK Neurosci Lett; 2002 May; 325(1):9-12. PubMed ID: 12023055 [TBL] [Abstract][Full Text] [Related]
44. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction. Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721 [TBL] [Abstract][Full Text] [Related]
45. TLR2 and TLR4 activation induces p38 MAPK-dependent phosphorylation of S6 kinase 1 in C2C12 myotubes. Zbinden-Foncea H; Deldicque L; Pierre N; Francaux M; Raymackers JM Cell Biol Int; 2012; 36(12):1107-13. PubMed ID: 22931089 [TBL] [Abstract][Full Text] [Related]
46. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Ning J; Clemmons DR Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874 [TBL] [Abstract][Full Text] [Related]
47. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle. Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856 [TBL] [Abstract][Full Text] [Related]
48. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells. Roca H; Varsos ZS; Pienta KJ Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839 [TBL] [Abstract][Full Text] [Related]
49. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. Singh K; Balligand JL; Fischer TA; Smith TW; Kelly RA J Biol Chem; 1996 Jan; 271(2):1111-7. PubMed ID: 8557638 [TBL] [Abstract][Full Text] [Related]
50. Involvement of tyrosine kinase and protein kinase C in the induction of nitric oxide synthase by lipopolysaccharide and interferon-gamma in J774 macrophages. Eason S; Martin W Arch Int Pharmacodyn Ther; 1995; 330(2):225-40. PubMed ID: 8861714 [TBL] [Abstract][Full Text] [Related]
51. Differences in nitric oxide synthase activity in a macrophage-like cell line, RAW264.7 cells, treated with lipopolysaccharide (LPS) in the presence or absence of interferon-gamma (IFN-gamma): possible heterogeneity of iNOS activity. Noda T; Amano F J Biochem; 1997 Jan; 121(1):38-46. PubMed ID: 9058189 [TBL] [Abstract][Full Text] [Related]